Insulet (PODD) Change in Receivables (2010 - 2025)
Insulet (PODD) reported Change in Receivables of $209.8 million for Q4 2025, up 23411.11% on a YoY basis from N/an in Q4 2024, and up 13012.5% quarter-over-quarter from $1.6 million in Q3 2025.
Insulet (PODD) Change in Receivables (2010 - 2025) Analysis & Trends
Insulet has reported Change in Receivables for 14 years, with the latest figure at $209.8 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables rose 23411.11% year-over-year to $209.8 million; the trailing twelve-month figure through Mar 2026 stood at $247.0 million (up 653.05% YoY), and the FY2025 full-year result was $253.2 million, up 3995.38% from the prior year.
- Change in Receivables for Q4 2025 stood at $209.8 million, up from $1.6 million in the prior quarter.
- The five-year high for Change in Receivables was $209.8 million in Q4 2025, with the low at -$33.1 million in Q1 2024.
- Historically, Change in Receivables has averaged $17.0 million across 5 years, with a median of $7.0 million in 2023.
- Annual changes were most pronounced in 2022 — Change in Receivables sank 15300.0% — and 2025, when it surged 23411.11%.
- Insulet's Change in Receivables stood at -$100000.0 in 2021, then slumped by 15300.0% to -$15.4 million in 2022, then soared by 357.14% to $39.6 million in 2023, then slumped by 102.27% to -$900000.0 in 2024, then surged by 23411.11% to $209.8 million in 2025.
- The last three Change in Receivables figures came in at $209.8 million (Q4 2025), $1.6 million (Q3 2025), and $35.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 209.80 Mn |
| Dec 31, 2025 | 209.80 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 35.60 Mn |
| Jun 30, 2025 | 35.60 Mn |
| Mar 31, 2025 | 6.20 Mn |
| Mar 31, 2025 | 6.20 Mn |
| Dec 31, 2024 | -900,000.00 |
| Dec 31, 2024 | -900,000.00 |
| Sep 30, 2024 | 14.30 Mn |
| Sep 30, 2024 | 14.30 Mn |
| Jun 30, 2024 | 13.20 Mn |
| Jun 30, 2024 | 13.20 Mn |
| Mar 31, 2024 | -33.10 Mn |
| Mar 31, 2024 | -33.10 Mn |
| Dec 31, 2023 | 39.60 Mn |
| Dec 31, 2023 | 39.60 Mn |
| Sep 30, 2023 | -11.90 Mn |
| Sep 30, 2023 | -11.90 Mn |